Stay updated on Apatinib Plus Pembrolizumab Clinical Trial
Sign up to get notified when there's something new on the Apatinib Plus Pembrolizumab Clinical Trial page.

Latest updates to the Apatinib Plus Pembrolizumab Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe page now notes that recruitment is closed, and adds user guidance sections such as 'How to Read a Study Record', 'Common Questions', and 'How to Join a Study'; a formatting change to the Intervention/Treatment header and a revision tag update are also included.SummaryDifference0.6%

- Check21 days agoChange DetectedRevision: v3.5.5 is now shown, updating the document's version. It represents a small metadata update rather than a change to the study details.SummaryDifference0.1%

- Check42 days agoChange DetectedThe revision label on the page changed from v3.5.3 to v3.5.4, indicating an update to the site; no study content or critical data was altered.SummaryDifference0.1%

- Check56 days agoChange DetectedThe page now shows Revision: v3.5.3, replacing Revision: v3.5.2. This reflects a minor site/version update rather than any changes to the study details.SummaryDifference0.1%

- Check71 days agoChange DetectedSite revision updated to v3.5.2, replacing the previous v3.5.0.SummaryDifference0.1%

- Check99 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0. No visible changes to the study details or page content.SummaryDifference0.1%

Stay in the know with updates to Apatinib Plus Pembrolizumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Apatinib Plus Pembrolizumab Clinical Trial page.